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INTRODUCTION:  Solid  pseudopapillary  neoplasm  (SPPN)  was  ﬁrst  characterized  by Virginia  Frantz  in
1959. The  duodenum-preserving  pancreatic  head  resection  (DPPHR)  has  been  described  as  treatment  for
low-grade  malignant  tumors  of the  head  of  the  pancreas  including  eight  cases  of  SPPN.
PRESENTATION  OF  CASE:  A  16-year-old  white  female  patient  presented  with  abdominal  pain  and  dys-
pepsia.  Computed  tomography  scan  of abdomen  showed  a 10 ×  9  ×  10 cm3 lesion  on  the  pancreatic
head. After  radiological  diagnosis  of  SPPN  the  patient  was  submitted  to DPPHR.  Resection  was  achieved
with clear margins.  Immunohistochemical  study  demonstrated  positivity  for progesterone  receptor,  -
catenin,  cytoplasmic  paranuclear  dot-like  CD99,  negativity  for chromogranin  and  S100  protein  and  Ki  67
index  of  1%.
DISCUSSION:  A  large  encapsulated  pancreatic  mass  with  well-deﬁned  borders  that  contains  areas  of  cal-
ciﬁcations  and  intratumoral  hemorrhage  on CT scan  in a young  female  is virtually  diagnostic  of an  SPPN.
A particular  dot-like  intracytoplasmic  expression  of CD99  appears  to be  highly  unique  for SPPN
CONCLUSION:  DPPHR  should  be  considered  in  cases  of  SPPN  in  the  pancreas  head if there  is  no  compromise
with  oncologic  radicality.
©  2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Solid pseudopapillary neoplasm (SPPN) was ﬁrst character-
zed by Virginia Frantz in 19591 and was deﬁned by The World
ealth Organization (WHO) as “solid pseudopapillary tumors” of
he pancreas in 1996.2 It is a neoplasm of unknown etiology, low
alignant potential and good prognosis that occurs most often in
oung women.3–5 Symptoms of SPPN are often nonspeciﬁc but the
adiological appearance is distinct from other pancreatic tumors.5,6
omplete resection has a favorable prognosis.7,8
Pancreatoduodenectomy is the most described surgical pro-
edure to treat SPPN in the head of the pancreas.3–8 The
uodenum-preserving pancreatic head resection (DPPHR) has been
escribed for treatment of low-grade malignant tumors of the head
f the pancreas including SPPN, if there is no compromise with
ncologic radicality.9,10
We  present a case of 16-year-old female patient with solid-
seudo papillary neoplasm submitted to duodenum-preserving
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pancreatic head resection. The histopathology examination and
immunohistochemical study conﬁrmed the diagnosis.
2. Presentation of case
Written informed consent was obtained from the patient for
publication of this case report and accompanying images. In
October 2012, a 16-year-old white female patient presented with
abdominal pain and dyspepsia, which started when she was at
age of 12. Computed tomography scan of abdomen showed a
10 × 9 × 10 cm lesion on the pancreatic head (Fig. 1). The radio-
logical diagnosis was of a solid pseudopapillary neoplasm. Serum
tumor markers were carcinoembryonic antigen (CEA): 0.8 ng/mL
and carbohydrate antigen 19-9 (CA 19.9): 50 U/mL The patient was
submitted to a duodenum-preserving pancreatic head resection
(Fig. 2). She had a very good recovery and was discharged on the
9th post-operative day.
Pathologic evaluation showed a well-demarcated encapsulated
tumor weighing 201.6 g and measuring 7.0 × 6.5 × 6.0 cm.  Section-
ing demonstrated a solid mass with soft areas, ﬁbrous bands
and hemorrhage focus, without cystic degeneration (Fig. 3). The
histological sections showed a neoplasm characterized by poly-
hedral/elongated cell proliferation, with round and pleomorphic
nuclei forming solid nests and papillae with ﬁbrovascular axes
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 1. Axial CT of the abdomen with intravenous contrast demonstrating a large
heterogeneous mass in the ventral head of the pancreas. The mass measures
approximately 10 × 9 × 10 cm in its maximum anterior-posterior, transverse and
craniocaudal dimensions, respectively.
Fig. 2. Duodenum preserving pancreatic head resection. Duodenum (white arrow),
superior mesenteric vein (blue arrow) and common bile duct (green arrow). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred
to  the web version of this article.).
Fig. 3. Cutting surface shows a solid mass (green arrow) and soft areas (white
arrow). (For interpretation of the references to color in this ﬁgure legend, the reader
is  referred to the web version of this article.).PEN  ACCESS
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(Fig. 4a). Clear margin was achieved. Immunohistochemical study
demonstrated strong and diffuse nuclear positivity for proges-
terone receptor, negativity for cromogranin and S100 protein,
nuclear and cytoplasmic positivity for -catenin and cytoplasmic
paranuclear dot-like positivity for CD99 and Ki 67 index of 1% (Fig. 4
b, c, d, e and f, respectively).
3. Discussion
Solid pseudopapillary neoplasm (SPPN) otherwise known
as solid and papillary tumor, solid-cystic tumor and Frantz’s
tumor, among others, was ﬁrst characterized by Virginia Frantz
in 1959 as a “papillary cystic tumor of the pancreas”. The
patient was  a 2-year-old boy who died during an attempted
duodenectopancreatectomy.1 The World Health Organization
(WHO) deﬁnes it as “solid pseudopapillary tumors” of the pancreas
since 1996.2
SPPN is an uncommon indolent cancer of unknown etiology,
low malignant potential and good prognosis that account for 2–3%
of primary pancreatic malignancies. SPPN occurs most often in
women during their second and third decades as a slow-growing
mass, and can arise at any location within the pancreas (head,
body, or tail), without a preferential site. If a complete resection
is achieved, most patients have a favorable prognosis, with higher
than 90% overall cure rate.7,8 However, 10–15% of the patients with
SPPN reported developing metastasis and/or recurrence.11,12
Symptoms of SPPN are often nonspeciﬁc and include abdom-
inal pain, dyspepsia, early satiety, nausea and vomiting.3–5 It is
distinct from other pancreatic tumors both in epidemiologic dis-
tribution as well as radiological appearance. A large encapsulated
pancreatic mass with well-deﬁned borders that contains areas of
calciﬁcations as well as intratumoral hemorrhage on CT scan in a
young female is virtually diagnostic of an SPPN.4–6 Our patient pre-
senting symptoms were comparable with previous literature, with
the most common complaint being abdominal pain.
Grossly, the tumor is a solid mass well circumscribed with
regions of necrosis, hemorrhage and cystic degeneration with a
thick ﬁbrous capsule. Histologically, the solid portions contain
sheets, cords and nets of uniform, rather small, and fairly round cells
in a rich and delicate vascular network. Many of the cells farthest
from the vessels undergo degeneration, causing the remaining
cells around the vessels to form pseudorosette or pseudopapil-
lary patterns.1,2,4 Rarely, the SPPN exhibit a high-grade component
that consists of diffuse sheets of cells with a high nucleus to cyto-
plasm ratio, necrosis and elevated mitotic activity suggesting the
development of a poorly differentiated carcinoma. These tumors
are associated with a rapidly progressive and fatal clinical course.13
The tumors show immunohistochemical stain for vimentin, 1-
antitrypsin, neuron-speciﬁc enolase, CD56 and CD10. Positivity
staining for chromogranin (a precursor of several neuroendocrine
peptides) is never seen. The abnormal immunohistochemical
nuclear localization of -catenin staining has been proposed as a
diagnostic aid. Corresponding loss of the cell surface expression of
E-cadherin is also seen, and these abnormalities likely contribute
to reduce cell cohesion that characterizes this neoplasm.14,15 A par-
ticular dot-like intracytoplasmic expression of CD99 appears to be
highly unique for SPPN.16,17 CD99 is a glycoprotein encoded by
the pseudoautosomal gene MIC2. It is typically present in Ewing
sarcomas (ES), primitive neuroectodermal tumors (PNETs), lym-
phoblastic lymphomas, synovial sarcoma and other solid tumors,
but the immunostaining in all those cases is almost exclusively
conﬁned to the cellular membrane. The characteristic cytoplas-
mic  paranuclear “dot-like” pattern described in SPPN has also
been found in colonic adenomas/adenocarcinomas, pituicytomas
and endometrial serous carcinomas with ES differentiation, but to
date it has not been described in any other type of endocrine or
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Fig. 4. Histopathology and immunohistochemical study in SPPN. (a) Round cells forming papillae with delicate ﬁbrovascular axes (haematoxylin and eosin; original magni-
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tcation ×200). (b) Progesterone receptor showing strong and diffuse nuclear positiv
tain  with positive internal control in a Langerhans islet (×200). (d) Nuclear and c
×400)  (e) Cytoplasmic paranuclear dot-like positivity for CD99 stain (×400). (f) Lo
xocrine pancreatic tumors included in the differential diagnosis
f SPPN.16,17
Several types of procedures have been developed to preserve
rgan function and reduce complications in patients with low-
rade malignancies of the pancreas if there is no compromise
ith oncologic radicality.9,10,18 The importance of duodenal preser-
ation in pancreatic surgery is that pancreatic enzyme secretion
nd endocrine function is not reduced after the DPPHR. This sur-
ical procedure preserves the stomach and pylorus and spares
he duodenum and the extrahepatic bile duct, which are impor-
ant for hormonal control of exocrine and endocrine pancreatic
unction.9,10
DPPHR was ﬁrst described by Beger et al. in 198520 for treatment
f chronic pancreatitis. Since then several modiﬁcations have been
eported to remove benign or low-grade malignant lesions in the
ead of the pancreas. In the conventional DPPHR an incomplete
ancreatic parenchymal resection is performed while a complete
arenchymal resection, including the groove area, is done in the
odiﬁed DPPHR.9,10 In the present case we performed a modiﬁed
PPHR as described by the previously cited authors, in which only
wo cases of SPPN was reported. the neoplastic cells (×200). (c) Negativity for chromogranin immunohistochemical
smic positivity for -catenin plus membrane staining in normal pancreatic tissue
7 (MIB-1) labeling index (×200).
We have found eight cases of SPPN treated with DPPHR. How-
ever because the details of the operation was not described in all
publications we  cannot afﬁrm exactly how many cases of SPPN
were treated by the same technique that we present in our case,
apart from the two  ones we  have mentioned before. In the series
of 11 patients21 in which ﬁve cases were treated by DPPHR, the
procedure performed was the technique ﬁrst described by Beger
et al.,20 that is different from the one we reported in our case, fur-
thermore, there was no report of DPPHR in the recent large series
of 64 patients reported by Estrella et al.8
SPPN rarely metastasize to the lymph nodes there-
fore aggressive regional lymphadenectomy is not routinely
recommended,19 but complete resection with negative margins is
imperative.5,7,8,19
In conclusion, DPHR should be considered in cases of SPPN
in the pancreatic head if there is no compromise with oncologic
radicality.Conﬂict of interest statement
Vivian Resende and other co-authors have no conﬂict of interest.
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